References
Reuler JB, Girard DE, Cooney TG (1985) Wernicke’s encephalopathy. N Engl J Med 312:1035–1039
Scalzo SJ, Bowden SC, Ambrose ML, Whelan G, Cook MJ (2015) Wernicke–Korsakoff syndrome not related to alcohol use: a systematic review. J Neurol Neurosurg Psychiatry 86:1362–1368
Walker MA, Zepeda R, Afari HA, Cohen AB (2014) Hearing loss in Wernicke encephalopathy. Neurol Clin Pract 4:511–515
Galvin R, Bråthen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA, EFNS (2010) EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol 17:1408–1418
Singh S, Kumar A (2007) Wernicke encephalopathy after obesity surgery: a systematic review. Neurology 68:807–811
Caine D, Halliday G, Kril J, Harper C (1997) Operational criteria for the classification of chronic alcoholics: identification of Wernicke’s encephalopathy. J Neurol Neurosurg Psychiatry 62:51–60
Foster D, Falah M, Kadom N, Mandler R (2005) Wernicke encephalopathy after bariatric surgery: losing more than just weight. Neurology 65:1987
Kohrman DC, Wan G, Cassinotti L, Corfas G (2019) Hidden hearing loss: a disorder with multiple Etiologies and mechanisms. Cold Spring Harb Perspect Med. pii: a035493
Chaves LC, Faintuch J, Kahwage S, Alencar Fde A (2002) A cluster of polyneuropathy and Wernicke–Korsakoff syndrome in a bariatric unit. Obes Surg 12:328–334
Moser T, Starr A (2016) Auditory neuropathy—neural and synaptic mechanisms. Nat Rev Neurol 12:135–149
Oudman E, Wijnia JW, van Dam M et al (2018) Preventing wernicke encephalopathy after bariatric surgery. Obes Surg 28:2060–2068
Kattah JC, Dhanani SS, Pula JH, Mantokoudis G, Tehrani ASS, Toker DEN (2013) Vestibular signs of thiamine deficiency during the early phase of suspected Wernicke encephalopathy. Neurol Clin Pract 3:460–468
Lee SH, Kim SH, Kim JM, Tarnutzer AA (2018) Vestibular dysfunction in Wernicke’s encephalopathy: predominant Impairment of the horizontal semicircular canals. Front Neurol 9:141
Funding
LP: consulting fees from Biogen, Novartis and Roche; speaker honoraria from Biogen, Genzyme, Merck Serono, Novartis and Teva; travel grants from Biogen, Genzyme, Novartis and Teva; research grants from the Italian MS Society (Associazione Italiana Sclerosi Multipla) and Genzyme. CT: honoraria for speaking and travel grant from Biogen, Sanofi-Aventis, Merck Serono, Bayer-Schering, Teva, Genzyme, Almirall and Novartis. AS, GG, CG: none declared.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
The patient provided informed oral and written consent in accordance with specific national laws and the ethics standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Rights and permissions
About this article
Cite this article
Prosperini, L., Stasolla, A., Grieco, G. et al. Non-alcoholic Wernicke encephalopathy presenting as bilateral hearing loss: a case report. J Neurol 266, 1027–1030 (2019). https://doi.org/10.1007/s00415-019-09220-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-019-09220-4